Related references
Note: Only part of the references are listed.Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients
George P. Christophi et al.
CLINICAL IMMUNOLOGY (2012)
Production and functions of IL-33 in the central nervous system
Satoko Yasuoka et al.
BRAIN RESEARCH (2011)
IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival
Heth R. Turnquist et al.
JOURNAL OF IMMUNOLOGY (2011)
Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats
Eric P. Mensah-Brown et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration
Joanna Mikita et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2
Silke Huber et al.
BLOOD (2010)
Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice
Ashley M. Miller et al.
CIRCULATION RESEARCH (2010)
IL-33 is a crucial amplifier of innate rather than acquired immunity
Keisuke Oboki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Disease-associated functions of IL-33: the new kid in the IL-1 family
Foo Y. Liew et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Alexander U. Luethi et al.
IMMUNITY (2009)
Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis
Joanna B. Tierney et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
Mariola Kurowska-Stolarska et al.
JOURNAL OF IMMUNOLOGY (2009)
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
J. Chapuis et al.
MOLECULAR PSYCHIATRY (2009)
A rush to judgment on Th17
Lawrence Steinman
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis
Richard A. O'Connor et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-33, a potent inducer of adaptive immunity to intestinal nematodes
Neil E. Humphreys et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4
Mariola Kurowska-Stolarska et al.
JOURNAL OF IMMUNOLOGY (2008)
Induction of IL-33 expression and activity in central nervous system glia
Chad A. Hudson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Foxp(3+) regulatory T cells in the control of experimental CNS autoimmune disease
Richard A. O'Connor et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis
Howard L. Weiner
JOURNAL OF NEUROLOGY (2008)
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Damo Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice
Waldiceu A. Verri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex
Alissa A. Chackerian et al.
JOURNAL OF IMMUNOLOGY (2007)
Glatiramer acetate: Mechanisms of action in multiple sclerosis
Wiebke Schrempf et al.
AUTOIMMUNITY REVIEWS (2007)
Effectors of demyelination and remyelination in the CNS: Implications for multiple sclerosis
Moses Rodriguez
BRAIN PATHOLOGY (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
Ralf Gold et al.
BRAIN (2006)
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis
Lawrence Steinman et al.
ANNALS OF NEUROLOGY (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Regulation of expression of the novel IL-1 receptor family members in the mouse brain
R Andre et al.
JOURNAL OF NEUROCHEMISTRY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance
EK Brint et al.
NATURE IMMUNOLOGY (2004)
Regulatory CD4+ T cells and the control of autoimmune disease
DC Wraith et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Experimental autoimmune encephalo myelitis: Cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease
BA Segal
CURRENT ALLERGY AND ASTHMA REPORTS (2003)
Share Paper
